相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T cell activation niches-Optimizing T cell effector function in inflamed and infected tissues*
Noor Bala et al.
IMMUNOLOGICAL REVIEWS (2022)
Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis
Yu-Min Chuang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
Pedro Bule et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors
Yu Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Interferons α and β in cancer: therapeutic opportunities from new insights
Ernest C. Borden
NATURE REVIEWS DRUG DISCOVERY (2019)
Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments
Anje Cauwels et al.
CANCER RESEARCH (2018)
Batf3 selectively determines acquisition of CD8+ dendritic cell phenotype and function
Janin Chandra et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin
Esben G. W. Schmidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Interferon with antitumor immunity
Tiffany C. Scharschmidt
Science Translational Medicine (2017)
Adolescent Participation in HPV Vaccine Clinical Trials: Are Parents Willing?
Jennifer Cunningham Erves et al.
JOURNAL OF COMMUNITY HEALTH (2017)
Delivering safer immunotherapies for cancer
Lauren Milling et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Don S. Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Batf3-dependent CD103+ dendritic cell accumulation is dispensable for mucosal and systemic antifungal host defense
Timothy J. Break et al.
VIRULENCE (2016)
Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+T-cell immune responses and antitumor effects without adjuvant
Ming-Chieh Yang et al.
CELL AND BIOSCIENCE (2016)
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Shiwen Peng et al.
CELL AND BIOSCIENCE (2016)
Cancer immunotherapy trials: leading a paradigm shift in drug development
Leisha A. Emens et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Who Benefits Most From Adjuvant Interferon Treatment for Melanoma?
Helen Gogas et al.
AMERICAN JOURNAL OF THERAPEUTICS (2015)
Recombinant Human Serum Albumin Fusion Proteins and Novel Applications in Drug Delivery and Therapy
Brian Rogers et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Intravaginal HPV DNA vaccination with electroporation induces local CD8+T-cell immune responses and antitumor effects against cervicovaginal tumors
Y. Sun et al.
GENE THERAPY (2015)
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis
Daniel Harari et al.
HUMAN MOLECULAR GENETICS (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Willingness to participate in future HIV prevention trials in Beira, Mozambique
Ivete Meque et al.
AJAR-AFRICAN JOURNAL OF AIDS RESEARCH (2014)
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow
Christian Thomas Mayer et al.
BLOOD (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
Samir Mitragotri et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
Joshua W. Wang et al.
PLOS ONE (2014)
Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
Leonel Maldonado et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects
Sung Yong Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Adjuvant Interferon Therapy for Patients at High Risk for Recurrent Melanoma: An Updated Systematic Review and Practice Guideline
T. Petrella et al.
CLINICAL ONCOLOGY (2012)
Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Improvement of different vaccine delivery systems for cancer therapy
Azam Bolhassani et al.
MOLECULAR CANCER (2011)
DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+T cell immunity
Shiwen Peng et al.
CELL AND BIOSCIENCE (2011)
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S. Daayana et al.
BRITISH JOURNAL OF CANCER (2010)
Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation
Andreia Soares et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Carrageenan as an adjuvant to enhance peptide-based vaccine potency
Yu-Qian Zhang et al.
VACCINE (2010)
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity
Balasubramanyam Karanam et al.
VACCINE (2009)
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus
G. Mani Subramanian et al.
CHEMOTHERAPY (2008)
Pretreatment with cisplatin enhances E7-specific CD8+ T-cell mediated antitumor immunity induced by DNA vaccination
Chih-Wen Tseng et al.
CLINICAL CANCER RESEARCH (2008)
Severe weight loss in HIV/HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors
F. Bani-Sadr et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers:: The ANRS VAC14 study
Gilles Pialoux et al.
VACCINE (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency
Bruce Huang et al.
VACCINE (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Side effects of interferon-α therapy
S Sleijfer et al.
PHARMACY WORLD & SCIENCE (2005)
Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C
MS Seyam et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
A Le Bon et al.
NATURE IMMUNOLOGY (2003)
Chemokines: Agents for the immunotherapy of cancer?
B Homey et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens
SH van der Burg et al.
VACCINE (2001)
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
E Jonasch et al.
ONCOLOGIST (2001)
In vivo cross-presentation of a soluble protein antigen: Kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes
D Nelson et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
